Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

A University of Iowa researcher is using federal funding to develop a new approach to combat ovarian cancer. According to the ...

Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

When Ellie Wilcock was hit by sharp pains in her abdomen and sudden bouts of fatigue in 2022, she blamed it on a urinary ...

Clemson University's first African American woman to become a tenured professor at Clemson University's College of Education ...

Good morning, ladies and gentlemen and welcome to Aspira Women's Health Incorporated Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following ...

The IDEAL team will test this new model on targets known to be relevant in ovarian cancer, the deadliest of gynecologic ...

LEANNE Battersby looks set to be left rattled in the coming days on Coronation Street. Over the past few months, fans of the ...

Pregnancy complicates a cancer diagnosis in many ways. So cancer treatment may need to be adjusted. Here’s what we know so ...

ATA 2024 spotlighted new research to help endocrinologists manage the subsequent fertility, bone health, and cardiovascular ...